SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. Its lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner on May 3, 2017 and is headquartered in Dallas, TX.

Forte Biosciences Inc

Forte Biosciences is surging after announcing a significant oversubscribed private placement to fund the development of its autoimmune pipeline, sparking heavy volume and intense speculation among traders. While the stock has attracted momentum-focused investors and triggered short-squeeze excitement, community sentiment remains sharply divided between those tracking technical breakout levels and skeptics concerned about long-term dilution and the company's clinical-stage status.

Fermi, Inc. engages in the development of energy infrastructure. It intends to develop an energy and data center development campus to support the needs of to-be-built AI infrastructure. The company was founded by Rick Perry, Toby Neugebauer and Griffin Perry on January 10, 2025 and is headquartered in Amrillo, TX.

Fermi Inc

Fermi LLC

Fermi LLC is currently a major focus for market participants due to high-conviction institutional accumulation and intense speculation regarding an impending tenant announcement for its large-scale data center campus. While the stock has seen heightened volatility driven by an ongoing proxy battle and a recently announced convertible note offering, investors remain fixated on the potential for a significant valuation re-rating once the company secures an anchor hyperscaler partnership.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson ($JNJ) is trending as investors favor its defensive stability and strong oncology pipeline ahead of earnings, while the community actively discusses the stock's role in portfolio rotation and potential M&A activity within the biotech sector.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is experiencing significant volatility and price pressure following quarterly results, as the market reacts to cooling growth metrics and heightened competition despite beating top and bottom-line estimates. The community is actively debating whether this decline represents an overreaction to temporary headwinds or a necessary valuation reset for a high-quality company with an undeniable competitive moat.

Freeport-McMoRan, Inc. engages in the mining of copper, gold, and molybdenum. It operates through the following segments: U.S. Copper Mines, South America Operations, Indonesia Operations, Molybdenum Mines, U.S. Rod and Refining, Atlantic Copper, and Corporate and Other. The U.S. Copper Mines segment operates open-pit copper mines in Morenci, Bagdad, Safford, Sierrita, Miami in Arizona and Chino, and Tyrone in New Mexico. The South America Operations segment includes Cerro Verde in Peru and El Abra in Chile. The Indonesia Operations segment handles the operations of the Grasberg minerals district that produce copper concentrate containing significant quantities of gold and silver. The Molybdenum Mines segment includes the Henderson underground mine and Climax open pit mine, both in Colorado. The U.S. Rod and Refining segment consists of copper conversion facilities located in North America and includes refinery and rod mills. The Atlantic Copper segment smelts and refines copper concentrate and markets refined copper and precious metals in slimes. The Corporate and Other segment offers other mining and eliminations, oil and gas operations, and other corporate and elimination items. The company was founded by James R. Moffett on November 10, 1987, and is headquartered in Phoenix, AZ.

Freeport-McMoRan Inc

Freeport-McMoRan (FCX) remains a high-conviction play for the community as the copper supercycle narrative intensifies, driven by structural supply deficits and aggressive AI infrastructure demand. While investors are closely monitoring operational updates at the Grasberg mine, sentiment is buoyed by rising copper prices and the companys strategic position as a top-tier producer of a critical security metal.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solar is experiencing significant volatility and institutional attention as investors position for upcoming earnings, with active debate surrounding potential Section 232 tariff decisions and the long-term impact of US domestic manufacturing policies. The community is focused on the stock's role as a primary beneficiary of AI-driven data center energy demand, balancing strong technical support levels against ongoing regulatory and trade-related uncertainties.

Personalis, Inc. engages in the provision of advanced genomic tests for cancer. The firm is also involved in providing sequencing and data analysis services to support population sequencing initiatives. The company was founded by Euan A. Ashley, Michael Snyder, Atul J. Butte, John S. West, and Russ B. Altman in February 2011 and is headquartered in Fremont, CA.

Personalis Inc

Personalis is trending as investor interest surges around reports that the cancer-diagnostics company is exploring a potential sale following takeover interest from Merck and other major industry suitors. The community is actively debating the implications of a potential bidding war, with many highlighting the stock's significant long-term growth potential and the strategic value of its partnerships within the precision oncology sector.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is currently experiencing high volatility as investors navigate conflicting sentiment between its potential as a long-term AI data center infrastructure play and broader sector headwinds like residential solar demand. The community remains deeply divided, with many debating the impact of proposed import policies on inverters while actively monitoring key support levels following recent sharp price swings.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum is trending as investors react to two executive orders from the Trump administration aimed at accelerating national quantum computing development and post-quantum cryptography migration. The community is actively debating the stock's valuation, questioning if recent policy news provides a sustainable catalyst for growth or if it serves as a temporary pump amid persistent concerns over cash burn and share dilution.

ProShares Trust II - ProShares Ultra Silver 2x Shares

ProShares Ultra Silver

ProShares Ultra Silver (AGQ) is facing heightened volatility as investors grapple with complex market interdependencies, including fluctuations in the U.S. dollar, treasury yields, and ongoing geopolitical tensions surrounding energy markets. The community is actively debating the sustainability of silver's industrial demand against supply shortages, with many traders closely monitoring the impact of daily leveraged decay and institutional sentiment on price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MacroGenics (MGNX) is a Great Momentum Stock: Should You Buy?

Does MacroGenics (MGNX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Sanofi Wins FDA Nod for Expanded Use of T1D Drug in Children

SNY wins FDA approval to expand Tzield's use in children with newly diagnosed stage 3 T1D, opening treatment to a broader patient group.

Broad-Based MedSurg Growth Likely to Aid MDT's Q4 Performance

Medtronic's Q4 results may get a lift from broad MedSurg growth, strong Cardiovascular demand and continued momentum in Diabetes.

MacroGenics (MGNX) Reports Q1 Loss, Tops Revenue Estimates

MacroGenics (MGNX) delivered earnings and revenue surprises of -1.75% and +12.83%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Wall Street’s Risk-On Frenzy Returns

Among the session’s standout movers were Quantum Computing, which blasted through more than $1 billion in trading volume after reporting massive revenue growth and expanding its quantum-photonics footprint. Meanwhile, speculative traders also rotated heavily into AI-linked names including Dreamland Limited and media turnaround story BuzzFeed, both of which are holding onto substantial gains throughout the session. $TGNT, $QUBT, $BZFD, $TDIC, $HTCO, $MGNX, $CNCK, $VSTS

Why Harmonic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

Harmonic Inc (HLIT) rose in pre-market trading after beating earnings expectations & raising guidance. Other gainers include Buzzfeed, MacroGenics, & SI-Bone.read more...

CeriBell, Inc. (CBLL) Reports Q1 Loss, Beats Revenue Estimates

CeriBell, Inc. (CBLL) delivered earnings and revenue surprises of -32.48% and +1.14%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates

Haemonetics (HAE) delivered earnings and revenue surprises of +1.04% and +2.43%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

MacroGenics (MGNX) to Release Quarterly Earnings on Tuesday

MacroGenics (NASDAQ:MGNX) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 12. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-12-macrogenics-inc-stock...

Will MacroGenics (MGNX) Report Negative Q1 Earnings? What You Should Know

MacroGenics (MGNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MacroGenics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of antibody-based therapeutics for the treatment of cancer. Its product pipeline includes Margetuximab, Flotetuzumab, Retifanlimab, Enoblituzumab, Tebotelimab, MGC018, MGD019, IMGC936, and MGD014 for infectious diseases. The company was founded by Scott E. Koenig, Jeffrey V. Ravetch, LeRoy E. Hood, Ruedi Aebersold, and Alan Aderem on August 14, 2000 and is headquartered in Rockville, MD.

Macrogenics Inc

MGNX Stock Hits 16-Month High, But This Analyst Sees Another 140% Potential Upside

Equity

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is pacing for a losing week as a semiconductor ($SMH) sell-off has dragged the market lower amid growing doubts about AI spending. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$4.49
Prev Close	$4.12
Open	$4.08
Dividend Yield	0.00%
50-Day Moving Average	$4.20
Beta	1.39
Avg. Volume	1.23M
PE Ratio	-4.04

52-Week High	$5.08
52-Week Low	$1.29
Market Capitalization	$261.88M
EPS (Annual)	-$1.18
Price to Book	13.46
Revenue Per Employee	$510,238.91

Feed

News

Sentiment

Earnings

Fundamentals

Info

MGNXMacrogenics Inc

Latest MGNX News